Genetic and epigenetic alterations in carcinogenesis

被引:59
|
作者
Sugimura, T [1 ]
Ushijima, T [1 ]
机构
[1] Natl Canc Ctr, Div Carcinogenesis, Chuo Ku, Tokyo 1040045, Japan
关键词
DNA methylation; carcinogenesis; genetic alteration; epigenetic alteration;
D O I
10.1016/S1383-5742(00)00005-3
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
precise and deliberate observations on tumors stand true for decades, and then meet mechanistic explanations. The presence of genetic alterations in tumors is now widely accepted, and explains the irreversible nature of tumors. However, observations on tissue differentiation indicated that it shares something in common with carcinogenesis, that is, "epigenetic" changes. Now, DNA methylation in CpG sites is known to be precisely regulated in tissue differentiation, and is supposed to be playing key roles. Many tumor suppressor genes are known to be inactivated by the hyper-methylation of their promoter regions. DNA methylation is connected to histone deacetylation and chromatin structure, and regulatory enzymes of DNA methylation are being cloned. Dedifferentiation, dis(dys)differentiation and convergence of cancer cells were studied phenotypically and biochemically, and are now explained from molecular aspects of disturbances in tissue-specific transcription factors. Spontaneous regression of malignant tumors enchanted researchers, and it is now noticed that genes inactivated by hypermethylation are frequently involved in tumors that relatively often undergo spontaneous regression. Carcinogenic mechanisms of some carcinogens seem to involve modifications of epigenetic switch, and some dietary factors also have the possibility to modify the switches. Based on the growing understanding of the roles of DNA methylation, several new methodologies were developed to make a genome-wide search for changes in DNA methylation. Now, a wave of new findings is in sight. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:235 / 246
页数:12
相关论文
共 50 条
  • [31] Transgenerational carcinogenesis: induction and transmission of genetic alterations and mechanisms of carcinogenesis
    Nomura, T
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2003, 544 (2-3) : 425 - 432
  • [32] Genetic and epigenetic alterations of myeloproliferative disorders
    Jelena D. Milosevic
    Robert Kralovics
    International Journal of Hematology, 2013, 97 : 183 - 197
  • [34] GENETIC AND EPIGENETIC ALTERATIONS OF EPITHELIOID GLIOBLASTOMA
    Adachi, J.
    Shirahata, M.
    Suzuki, T.
    Mishima, K.
    Nishikawa, R.
    NEURO-ONCOLOGY, 2024, 26
  • [35] Genetic and epigenetic alterations in colon cancer
    Grady, WM
    Markowitz, SD
    ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2002, 3 : 101 - 128
  • [36] Genetic and Epigenetic Alterations in Bladder Cancer
    Li, Hong-Tao
    Duymich, Christopher E.
    Weisenberger, Daniel J.
    Liang, Gangning
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2016, 20 : 84 - 94
  • [37] Genetic and epigenetic alterations in urothelial carcinoma
    Lin, Hon-Yi
    Chan, Michael W. Y.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1192 - S1195
  • [38] Review of genetic and epigenetic alterations in hepatocarcinogenesis
    Herath, NI
    Leggett, BA
    Macdonald, GA
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (01) : 15 - 21
  • [39] Genetic and epigenetic alterations in myelodysplastic syndrome
    Mihara, K.
    Takihara, Y.
    Kimura, A.
    CYTOGENETIC AND GENOME RESEARCH, 2007, 118 (2-4) : 297 - 303
  • [40] Genetic and epigenetic alterations of myeloproliferative disorders
    Milosevic, Jelena D.
    Kralovics, Robert
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (02) : 183 - 197